Purity, activity, and virus safety of a pasteurized antithrombin concentrate

被引：6
|
作者：
Gröner, A
Nowak, T
Römisch, J
机构：
[1] Aventis Behring GmbH, D-35002 Marburg, Germany
[2] Res Labs Aventis Behring GmbH, Marburg, Germany
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2002年 / 28卷
关键词：
D O I：
10.1055/s-2002-30200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 85
页数：7
相关论文
共 50 条
  • [41] Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency during Surgery or Childbirth
    Schwartz, Bruce A.
    Solomon, Cristina
    Knaub, Sigurd
    Kessler, Craig M.
    BLOOD, 2021, 138
  • [42] DEFICIENCY OF ANTITHROMBIN-III ACTIVITY AFTER FACTOR-IX CONCENTRATE THERAPY
    HULTIN, MB
    CIRCULATION, 1982, 66 (04) : 322 - 322
  • [43] A HIGHLY PURIFIED AND PASTEURIZED VONWILLEBRAND-FACTOR CONCENTRATE
    HEIMBURGER, W
    KUMPE, G
    WEILNER, K
    TRANSFUSION, 1991, 31 (04) : 376 - 376
  • [44] Viral safety of a pasteurized, monoclonal antibody-purified factor VIII concentrate in previously untreated haemophilia A patients
    Philipp, CS
    HAEMOPHILIA, 2001, 7 (02) : 146 - 153
  • [45] Hereditary angio-edema - Efficacy and safety of prophylaxis with pasteurized C1-inhibitor concentrate.
    Heller, C
    Martinez, I
    Fischer, D
    Kreuz, W
    BLOOD, 1998, 92 (10) : 49A - 49A
  • [46] ANTITHROMBIN CONCENTRATE AS ADJUVANS IN THE TREATMENT OF ACQUIRED ANTITHROMBIN DEFICIENCY DURING PREGNANCY AND DELIVERY
    HELLGREN, M
    ROBBE, H
    HAGNEVIK, K
    FAXELIUS, G
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1984, 3 (2-3): : 279 - 279
  • [47] Efficacy and safety evaluation in children with VWD following product switch to a new generation high purity, double virus inactivated VWF/FVIII concentrate
    Khair, K.
    Mathias, M.
    Liesner, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 667 - 667
  • [48] Continued efficacy and safety of a new generation high purity, double virus inactivated VWF/FVIII concentrate in children with VWD following product switch
    Bartram, J.
    Efford, J.
    Henderson, L.
    Liesner, R.
    Mathias, M.
    Khair, K.
    HAEMOPHILIA, 2012, 18 : 196 - 196
  • [49] COMPARING INVESTIGATION OF ANTITHROMBIN-III-CONCENTRATE
    DORNHEIM, G
    TOPFER, G
    PHARMAZIE, 1987, 42 (12): : 867 - 868
  • [50] Use of recombinant human antithrombin concentrate in pregnancy
    Kreuziger, Lisa M. Baumann
    Prosen, Tracy L.
    Reding, Mark T.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 583 - 585
12345